Viral hepatitis among people who inject drugs

Auditorium IV
In programme
Thursday, 24 October, 2024 - 16:50 to 18:20
View presentations

About

This session will cover strategies for addressing hepatitis C and B within high-risk populations in community and prisons.

Chair

Dore Gregory
  • Head, Viral Hepatitis Clinical Research Program,
  • Kirby Institute, UNSW,
  • Australia
Ward Zoe
  • Research Fellow,
  • University of Bristol,
  • United Kingdom

Type

Tracks

Keywords

Presentations

Thursday, 24 October

16:50
Oral presentation

Epidemiology of injecting drug use and injection related harms among people who are incarcerated

16:50 to 18:20
Auditorium IV
Louisa Degenhardt
Oral presentation

Context specific factors that impact on the optimal scale up of hepatitis C testing and treatment in the UK

16:50 to 18:20
Auditorium IV
Peter McCulloch
Oral presentation

The development of a toolkit to support the elimination of viral hepatitis B and C in prisons

16:50 to 18:20
Auditorium IV
Erika Duffell
Oral presentation

Towards elimination of hepatitis C in Oslo: cross-sectional prevalence studies in 2018, 2021, 2022 and 2023

16:50 to 18:20
Auditorium IV
Eirik Opheim
View the programme